LEND: Contemporary Ototoxicity Among Patients With High-Risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL1531
Product Description:
Evaluation of cisplatin induced hearing loss in a cohort of children treated with cisplatin for neuroblastoma. Among evaluable patients, 69% had SIOP grade 2 or worse ototoxicity in at least one ear.
Keyword(s):
childhood cancer, cisplatin, hearing loss, neuroblastoma, ototoxicity
Product/Publication Type(s):
Peer-reviewed publications in scholarly journals Published/In Press
Target Audience:
Professionals, Policymakers
To Obtain Copies (URL or Email):
COVID-19 Related Data:
N/A